Generali

Model update: NatCat hits Generali

29/11/23 -"We have cut our Generali Target Price due to the weaker H2 which was impacted by higher NatCat losses than had been forecast in our previous model. Despite maintaining a cautious outlook, we ..."

PDF page sample
Pages
64
Language
English
Published on
29/11/23
Download
You may also be interested by these reports :
06/11/25
Zurich delivered a solid set of Q3 top-line figures, with good momentum at Farmers and in Life. In P&C, while profitability has improved ...
06/11/25
We have reviewed our assumptions for 2025 and the subsequent years. We have notably assumed a slight deterioration in the P&C attritional ratio in ...
05/11/25
Sampo’s 3Q results were broadly in line at the operating level. The Solvency II ratio fell short of consensus, but this was mainly due to the newly ...
05/11/25
Sampo’s Q3 results were broadly in line with our estimates at the underwriting result level. The upgrade to our FY25 EPS estimate mainly reflects the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO